• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Infliximab-induced autoimmune hepatitis with successful switch to adalimumab in a patient with Crohn's disease: the index case.

作者信息

Goldfeld Dahlia A, Verna Elizabeth C, Lefkowitch Jay, Swaminath Arun

机构信息

Columbia University Graduate School of Arts and Sciences, New York, NY, USA.

出版信息

Dig Dis Sci. 2011 Nov;56(11):3386-8. doi: 10.1007/s10620-011-1748-1. Epub 2011 May 20.

DOI:10.1007/s10620-011-1748-1
PMID:21597977
Abstract
摘要

相似文献

1
Infliximab-induced autoimmune hepatitis with successful switch to adalimumab in a patient with Crohn's disease: the index case.英夫利昔单抗诱导的自身免疫性肝炎，克罗恩病患者成功换用阿达木单抗：首例病例
Dig Dis Sci. 2011 Nov;56(11):3386-8. doi: 10.1007/s10620-011-1748-1. Epub 2011 May 20.
2
Autoimmune hepatitis induced by infliximab in a patient with Crohn's disease with no relapse after switching to adalimumab.英夫利昔单抗诱导克罗恩病患者发生自身免疫性肝炎，转换用阿达木单抗后无复发。
BioDrugs. 2010 Dec 14;24 Suppl 1:25-7. doi: 10.2165/11586210-000000000-00000.
3
Autoimmune hepatitis during infliximab therapy for Crohn's disease: a case report.英夫利昔单抗治疗克罗恩病时发生自身免疫性肝炎：病例报告。
J Crohns Colitis. 2011 Jun;5(3):253-5. doi: 10.1016/j.crohns.2010.12.007. Epub 2011 Feb 11.
4
Infliximab-induced acute hepatitis during Crohn's disease therapy: absence of cross-toxicity with adalimumab.英夫利昔单抗治疗克罗恩病期间诱发的急性肝炎：与阿达木单抗无交叉毒性。
Gastroenterol Clin Biol. 2010 Sep;34(8-9):e7-8. doi: 10.1016/j.gcb.2010.01.016. Epub 2010 Feb 26.
5
Infliximab and adalimumab-induced thrombocytopenia in a woman with colonic Crohn's disease.英夫利昔单抗和阿达木单抗诱发一名患有结肠克罗恩病女性的血小板减少症。
Gut. 2007 Aug;56(8):1169-70. doi: 10.1136/gut.2007.123547. Epub 2007 Mar 7.
6
Switch to adalimumab in patients with Crohn's disease controlled by maintenance infliximab: prospective randomised SWITCH trial.切换至阿达木单抗治疗维持缓解的英夫利昔单抗治疗克罗恩病患者：前瞻性随机 SWITCH 试验。
Gut. 2012 Feb;61(2):229-34. doi: 10.1136/gutjnl-2011-300755. Epub 2011 Sep 23.
7
Autoimmune hepatitis following treatment with infliximab for inflammatory bowel disease.英夫利昔单抗治疗炎性肠病后发生的自身免疫性肝炎。
J Crohns Colitis. 2012 Jun;6(5):630-1. doi: 10.1016/j.crohns.2012.01.017. Epub 2012 Feb 9.
8
Acute and delayed hypersensitivity reactions to infliximab and adalimumab in a patient with Crohn's disease.克罗恩病患者对英夫利昔单抗和阿达木单抗的急性和迟发性超敏反应。
J Crohns Colitis. 2012 Feb;6(1):108-11. doi: 10.1016/j.crohns.2011.08.001. Epub 2011 Aug 31.
9
Adalimumab-induced lupus erythematosus in Crohn's disease patients previously treated with infliximab.阿达木单抗诱导的狼疮性红斑，发生于既往接受英夫利昔单抗治疗的克罗恩病患者。
Gut. 2008 Apr;57(4):559; author reply 559-60.
10
Adalimumab for orbital myositis in a patient with Crohn's disease who discontinued infliximab: a case report and review of the literature.阿达木单抗治疗克罗恩病停用英夫利昔单抗后发生眼眶肌炎 1 例报告并文献复习
BMC Gastroenterol. 2013 Apr 4;13:59. doi: 10.1186/1471-230X-13-59.

引用本文的文献

1
Focus on Anti-Tumour Necrosis Factor (TNF)-α-Related Autoimmune Diseases.关注抗肿瘤坏死因子 (TNF)-α 相关自身免疫性疾病。
Int J Mol Sci. 2023 May 3;24(9):8187. doi: 10.3390/ijms24098187.
2
Rituximab-induced autoimmune hepatitis: A case study and literature review.利妥昔单抗诱导的自身免疫性肝炎：一例病例研究及文献综述。
Can Liver J. 2020 Nov 17;3(4):381-386. doi: 10.3138/canlivj-2020-0009. eCollection 2020 Fall.
3
Infliximab-induced autoimmune hepatitis.英夫利昔单抗诱导的自身免疫性肝炎。

本文引用的文献

1
Hepatotoxicity of agents used in the management of inflammatory bowel disease.用于治疗炎症性肠病的药物的肝毒性。
Dig Dis. 2010;28(3):508-18. doi: 10.1159/000320410. Epub 2010 Sep 30.
2
Risk of elevated liver enzymes associated with TNF inhibitor utilisation in patients with rheumatoid arthritis.类风湿关节炎患者使用 TNF 抑制剂与肝酶升高的风险。
Ann Rheum Dis. 2010 Sep;69(9):1612-7. doi: 10.1136/ard.2009.112136. Epub 2010 May 6.
3
Infliximab-induced acute hepatitis during Crohn's disease therapy: absence of cross-toxicity with adalimumab.
BMJ Case Rep. 2021 May 24;14(5):e239944. doi: 10.1136/bcr-2020-239944.
4
Biologic and Checkpoint Inhibitor-Induced Liver Injury: A Systematic Literature Review.生物制剂和检查点抑制剂所致肝损伤：一项系统文献综述
Hepatol Commun. 2020 Jan 2;4(2):172-184. doi: 10.1002/hep4.1465. eCollection 2020 Feb.
5
Infliximab-induced autoimmune hepatitis requiring liver transplantation.英夫利昔单抗诱导的自身免疫性肝炎，需进行肝移植。
Clin Case Rep. 2019 Sep 27;7(11):2135-2139. doi: 10.1002/ccr3.2456. eCollection 2019 Nov.
6
Role of Biologics in the Development of Autoimmune Hepatitis: A Review.生物制剂在自身免疫性肝炎发展中的作用：综述
J Clin Transl Hepatol. 2018 Dec 28;6(4):402-409. doi: 10.14218/JCTH.2018.00039. Epub 2018 Dec 15.
7
Harmful Effects and Potential Benefits of Anti-Tumor Necrosis Factor (TNF)-α on the Liver.抗肿瘤坏死因子-α（TNF-α）对肝脏的有害影响和潜在益处。
Int J Mol Sci. 2018 Jul 27;19(8):2199. doi: 10.3390/ijms19082199.
8
Hepatic manifestations of non-steroidal inflammatory bowel disease therapy.非甾体类抗炎性肠病治疗的肝脏表现
World J Hepatol. 2015 Nov 28;7(27):2716-28. doi: 10.4254/wjh.v7.i27.2716.
9
Clinical Presentation and Outcomes of Autoimmune Hepatitis in Inflammatory Bowel Disease.炎症性肠病中自身免疫性肝炎的临床表现及预后
Dig Dis Sci. 2015 Oct;60(10):2873-80. doi: 10.1007/s10620-015-3699-4. Epub 2015 May 22.
10
Anti-tumour necrosis factor agent and liver injury: literature review, recommendations for management.抗肿瘤坏死因子药物与肝损伤：文献综述及管理建议
World J Gastroenterol. 2014 Dec 14;20(46):17352-9. doi: 10.3748/wjg.v20.i46.17352.
英夫利昔单抗治疗克罗恩病期间诱发的急性肝炎：与阿达木单抗无交叉毒性。
Gastroenterol Clin Biol. 2010 Sep;34(8-9):e7-8. doi: 10.1016/j.gcb.2010.01.016. Epub 2010 Feb 26.
4
Infliximab-related hepatitis: discussion of a case and review of the literature.英夫利昔单抗相关性肝炎：病例讨论及文献复习。
Intern Emerg Med. 2010 Jun;5(3):193-200. doi: 10.1007/s11739-009-0342-4. Epub 2010 Jan 27.
5
Simplified criteria for the diagnosis of autoimmune hepatitis.自身免疫性肝炎诊断的简化标准。
Hepatology. 2008 Jul;48(1):169-76. doi: 10.1002/hep.22322.